Close Menu

NEW YORK ─ The US Food and Drug Administration on Thursday granted Emergency Use Authorization to Ontario, Canada-based Pro-Lab Diagnostics to conduct its Pro-AmpRT SARS-CoV-2 lab-developed test at the firm's Round Rock, Texas CLIA-certified facility.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.